Andreas Halvorsen - Viking Global Investors
Holding/activity history for Ginkgo Bioworks Holdings, Inc. (DNA)
← All DNA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 3,577,128 | 0.06 | $6.13 | $21,927,795 | SEC | ||
| 2025 Q4 | 3,577,128 | 0.08 | $8.31 | $29,725,934 | SEC | ||
| 2025 Q3 | 3,577,128 | 0.14 | $14.58 | $52,154,526 | SEC | ||
| 2025 Q2 | 3,577,128 | 0.12 | $11.25 | $40,242,690 | SEC | ||
| 2025 Q1 | 3,577,128 | 0.06 | $5.70 | $20,389,630 | SEC | ||
| 2024 Q4 | 3,577,128 | 0.11 | $9.82 | $35,127,397 | SEC | ||
| 2024 Q3 | 3,577,128 | 0.11 | $8.15 | $29,153,593 | SEC | ||
| 2024 Q2 | 3,577,128 | 0.18 | $13.20 | $47,833,358 | SEC | ||
| 2024 Q1 | 3,577,128 | 0.62 | $46.40 | $165,978,746 | SEC | ||
| 2023 Q4 | 3,577,128 | 0.89 | $67.60 | $241,813,863 | SEC | ||
| 2023 Q3 | 3,577,128 | 1.05 | $72.40 | $258,984,078 | SEC | ||
| 2023 Q2 | 3,577,128 | 1.09 | $74.40 | $266,138,335 | SEC | ||
| 2023 Q1 | 3,577,128 | 0.90 | Add 126.81% | 0.50 | $46.60–90.00 · VW $63.28i | $190,303,218 | SEC |
| 2022 Q4 | 1,577,128 | 0.54 | Reduce 38.05% | 0.56 | $62.80–140.80 · VW $92.60i | $106,613,863 | SEC |
| 2022 Q3 | 2,545,853 | 1.47 | Add 275.99% | 1.08 | $89.40–196.40 · VW $124.74i | $317,722,000 | SEC |
| 2022 Q2 | 677,103 | 0.30 | Reduce 46.95% | 0.39 | $83.60–176.40 · VW $118.94i | $64,460,000 | SEC |
| 2022 Q1 | 1,276,379 | 0.84 | Reduce 84.94% | 6.94 | $104.80–350.80 · VW $181.13i | $205,752,000 | SEC |
| 2021 Q4 | 8,476,379 | 8.17 | $332.40 | $2,817,548,000 | SEC | ||
| 2021 Q3 | 8,476,379 | 10.88 | Buy | 10.88 | $356.00–570.00 · VW $425.82i | $3,929,649,000 | SEC |
Price snapshot:
Current price$9.05
Avg. buy price$124.50
+/- since buy-92.73%
52-week low$5.37
52-week high$17.58